Further analysis of multiple single clinicopathological parameters indicated that TP53 loss was a specific factor that determine the CIN status between the CIN low and high groups because other factors didn’t show significant impact (Table 3). The gene discussed is TP53; the disease is cervical squamous intraepithelial neoplasia.